Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I have a core position in SRPT in an IRA. Been fun trading the high 60’s to 80ish channel over past year or so.
Good Luck about to board a plane back to the States!
My large positions are this and $SOF.I @ 11.20
Yes it has. Especially considering biotech and therapeutics are out of favour for awhile.
It’s been a decent trade
I was early buying these 68's but....added some 61's and 63's so actually am ahead right now. Nice comeback for SRPT today with the markets!
Bought a few more shares just now in low 68's.
Good Luck!
Have very few shares left….good luck to us.
Lightened the load but Monday is a big news update regarding 9001-102 with JP
Morgan conference at 10:30AM
This thing is just gonna chill at 80-85 until DI gets his hand outta his ass and updates 102 in January
Same with $M
I’m anticipating a great 2022 especially with all the insider buying and anticipated news in January
I have been holding a smallish core position in an IRA and trading 100 size lots when appropriate. I usually let some go on good up days.
Otherwise.....be careful out there.
M...did let go of my entire position.
I rebought my entire position and some with a now $79 average.
I was waiting for 120.
And sold for a massive profit that was told to be “dead money”
It’s funny, cause atown is right again!
Srpt
I'm waiting for 120.00
the dilution news was GREAT !!
You’re right
Out at 94.52!
wow....down 11.85....
this is much worse than dead money....
lol....
so much bullshit...don't even know where to start...
what was good about it ?
please be precise, thanks !
there's no truth to any of that....
Sorry out at 94.52
Nope, but long term hopefully be good! I’ll be waiting to get back in, out at 92!
looks like the public doesn't like dilution...
https://www.sec.gov/Archives/edgar/data/873303/000119312521296879/d239735d424b5.htm
wow....tanking again....
this stock can't take any more " good " news !
blood red...
Again?
I love 50% gains
blood red again....
down 8.13 on " good " news...hate to see bad news...lol...
There is absolutely no truth to this at all
“Dead money”
I do just fine, dude...
but thanks anyway !
Dude you have to know when to trade em.
Good Luck!
Yeah but dropping well my core is all I have left now so its holding in an IRA.
Good Luck!
lol....now that's funny....
this stock is where good money came to die...
Jan 07 2021 168.95
but everyone is killing it I guess....lol...
Hell yes! Go SRPT! We’ll see what Monday brings!
Damn! Monday announcement coming apparently it might be good.
“Dead money”
Probably why the stock has been creeping upwards.
Big news this morning on the 9001 trial. Could be a Game change
96.05 close today….not a myth!
Impressive move for this “dead” stock and way to go. I just have my core position left.
I’m holding for $120 short term.
With Pfizer pretty much out of DMD sarepta is 90%+ of the pipeline
New trial announcement coming, it’s going to go up especially on a technical standpoint above 98-99.
Cheers!
Hard to believe it is still green in this market.
Hard to believe i sold that at $10
SMH
Just holding my core now completely out of my trading account. Good luck to us!
Our old friend (M) is breaking out have a core there too.....but just sold my first bunch.
“Dead money”
MYTH and his excellent predictions
Bought another 1470 shares yesterday
“Dead money”
Since then a large % gain has been made
What an absolutely pathetic prediction
Followers
|
128
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
3055
|
Created
|
11/16/05
|
Type
|
Free
|
Moderators |
http://www.sareptatherapeutics.com/
http://www.antivirals.com/
http://finance.yahoo.com/q/h?s=AVII
http://www.form4oracle.com/company?cik=0000873303&ticker=avii
http://www.secform4.com/insider-trading/873303.htm
Sarepta Therapeutics - formerly AVI BioPharma - remains focused on developing first-in-class, RNA-based therapeutics to improve and save the lives of people affected by serious and life-threatening rare and infectious diseases. Sarepta's unique technology has yielded a diverse pipeline of RNA-based therapeutics that include our lead clinical candidate, eteplirsen, for the treatment of Duchenne muscular dystrophy, a debilitating and life-threatening genetic disorder, as well as potential treatments for some of the world's most lethal infectious diseases.
Our exceptional science- and commercialization-focused team is committed to realizing our vision of becoming a leading, independent biotechnology company dedicated to translating our RNA-based science into transformational therapeutics and, most importantly, bringing these novel therapeutics to patients who have no other options.
AVI BioPharma, Inc., a biopharmaceutical company, develops therapeutic products principally based on NEUGENE antisense technology. It offers various drugs for the treatment of cardiovascular diseases, infectious diseases, cancer, and polycystic kidney diseases, as well as for regulating drug metabolism. The company has collaboration agreement with Chiron Corporation for research, development, and commercialization of antisense therapeutics against hepatitis C virus; Cook Group Incorporated for the development and commercialization of products for vascular diseases; and Ercole Biotech, Inc. to identify and develop drugs that direct the splicing of messenger RNA to treat a range of genetic and acquired diseases. AVI BioPharma was founded in 1980 and is based in Portland, Oregon.
Form Type | Received | Period Ending | Size | Report |
---|---|---|---|---|
PRE 14A | May 16, 2016 | Jun 27, 2016 | 2.7 MB | PDF RTF HTML XLS |
SC 13G | May 6, 2016 | 14.4 KB | PDF RTF HTML XLS | |
8-K | May 5, 2016 | May 5, 2016 | 72.4 KB | PDF RTF HTML XLS |
10-Q | May 5, 2016 | Mar 31, 2016 | 5.0 MB | PDF RTF HTML XLS |
10-K/A | Apr 29, 2016 | Dec 31, 2015 | 2.0 MB | PDF RTF HTML XLS |
4 | Apr 22, 2016 | Apr 20, 2016 | 5.0 KB | PDF RTF HTML XLS |
4 | Mar 17, 2016 | Mar 14, 2016 | 7.4 KB | PDF RTF HTML XLS |
4 | Mar 17, 2016 | Mar 14, 2016 | 5.2 KB | PDF RTF HTML XLS |
4 | Mar 17, 2016 | Mar 14, 2016 | 4.7 KB | PDF RTF HTML XLS |
8-K | Mar 8, 2016 | Mar 7, 2016 | 30.8 KB | PDF RTF HTML XLS |
Phone and email address..................Lead investigator in the DMD trial.....London College of Medicine
http://www1.imperial.ac.uk/medicine/people/f.muntoni/
DISCLAIMER:
•The Board Monitor and The Board Assistants herewith, Are not licensed brokers and assume NO Responsibility for the Actions,
Investment decisions, and or Messages Posted on this Forum.
•We do NOT recommend that Anyone Buy or Sell any Securities Posted Herewith.
Any Trade entered into Risks the Possibility of Losing the Funds Invested.
•There are NO Guarantees when Buying or Selling Any Security.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |